Miss Kandace Lyna Thomas, CNM, MSN | |
801 17th St Ne, Washington, DC 20002-7200 | |
(202) 398-5520 | |
(202) 396-6953 |
Full Name | Miss Kandace Lyna Thomas |
---|---|
Gender | Female |
Speciality | Certified Nurse Midwife (cnm) |
Experience | 15 Years |
Location | 801 17th St Ne, Washington, District Of Columbia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144451758 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | RN1016488 (District Of Columbia) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
George Washington University Medical Faculty Associates | 4082528898 | 651 |
News Archive
A Danish-British research team has discovered a turbo switch in the vital calcium pump in our body's cells. In studies at the X-ray source DORIS at Deutsches Elektronen-Synchrotorn DESY in Hamburg and the European Synchrotron Radiation Facility ESRF in Grenoble the team discovered that the on-off switch of the pump has a previously unknown third position, which switches the pump into a turbo gear.
Unigene Laboratories, Inc. has reported its financial results for the quarter ended June 30, 2010.
YEDA Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science, Israel, and XL-protein GmbH, Germany, a privately owned biopharmaceutical company, have signed a business collaboration agreement to commercialize a PASylated interferon superagonist - PAS-YNSα8 - which has been jointly developed by scientists at the Weizmann Institute and XL-protein.
While increased screening continues to drive down overall colorectal cancer rates, the rate of colorectal cancer in patients under age 50 is increasing, and the disease is commonly more aggressive in these young patients.
› Verified 3 days ago
Entity Name | Medical Faculty Associates, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417990581 PECOS PAC ID: 4082528898 Enrollment ID: O20031117000341 |
News Archive
A Danish-British research team has discovered a turbo switch in the vital calcium pump in our body's cells. In studies at the X-ray source DORIS at Deutsches Elektronen-Synchrotorn DESY in Hamburg and the European Synchrotron Radiation Facility ESRF in Grenoble the team discovered that the on-off switch of the pump has a previously unknown third position, which switches the pump into a turbo gear.
Unigene Laboratories, Inc. has reported its financial results for the quarter ended June 30, 2010.
YEDA Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science, Israel, and XL-protein GmbH, Germany, a privately owned biopharmaceutical company, have signed a business collaboration agreement to commercialize a PASylated interferon superagonist - PAS-YNSα8 - which has been jointly developed by scientists at the Weizmann Institute and XL-protein.
While increased screening continues to drive down overall colorectal cancer rates, the rate of colorectal cancer in patients under age 50 is increasing, and the disease is commonly more aggressive in these young patients.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Miss Kandace Lyna Thomas, CNM, MSN 801 17th St Ne, Washington, DC 20002-7200 Ph: (202) 398-5520 | Miss Kandace Lyna Thomas, CNM, MSN 801 17th St Ne, Washington, DC 20002-7200 Ph: (202) 398-5520 |
News Archive
A Danish-British research team has discovered a turbo switch in the vital calcium pump in our body's cells. In studies at the X-ray source DORIS at Deutsches Elektronen-Synchrotorn DESY in Hamburg and the European Synchrotron Radiation Facility ESRF in Grenoble the team discovered that the on-off switch of the pump has a previously unknown third position, which switches the pump into a turbo gear.
Unigene Laboratories, Inc. has reported its financial results for the quarter ended June 30, 2010.
YEDA Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science, Israel, and XL-protein GmbH, Germany, a privately owned biopharmaceutical company, have signed a business collaboration agreement to commercialize a PASylated interferon superagonist - PAS-YNSα8 - which has been jointly developed by scientists at the Weizmann Institute and XL-protein.
While increased screening continues to drive down overall colorectal cancer rates, the rate of colorectal cancer in patients under age 50 is increasing, and the disease is commonly more aggressive in these young patients.
› Verified 3 days ago
Amanda Booth, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2150 Pennsylvania Ave Nw, Washington, DC 20037 Phone: 202-741-3000 | |
Brenda Baffour-addo, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Mary Curtis, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2333 Ontario Rd Nw, Washington, DC 20009 Phone: 202-483-8196 Fax: 202-332-0541 | |
Mindy Greenside, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2333 Ontario Rd Nw, Washington, DC 20009 Phone: 202-420-7141 Fax: 202-332-0541 | |
Mrs. Ana Luisa Nascimento, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3020 14th St Nw, Washington, DC 20009 Phone: 202-745-4300 Fax: 202-232-8910 | |
Mrs. Karen J Pelote, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 801 17th St Ne, Washington, DC 20002 Phone: 202-398-5529 Fax: 202-396-6953 | |
Ms. Elizabeth Lamme, Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3828 Georgia Ave Nw, Apt 535, Washington, DC 20011 Phone: 585-727-9042 |